慢性心力衰竭患者的药理动力学变化:系统性审查
Olga Butranova1, Sergey Zyryanov1,2, Yury Kustov1
1Department of General and Clinical Pharmacology, Peoples' Friendship University of Russia Named After Patrice Lumumba (RUDN), 6 Miklukho-Maklaya St., 117198 Moscow, Russia.
International journal of molecular sciences
|October 16, 2025
概括
本综述探讨了药物特性如何影响慢性心力衰竭 (CHF) 患者的药理动力学. 了解这些变化对于优化复杂健康状况的老年人药物剂量至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 老年病的医生 老年病的医生
- 心脏病学 心脏病学
背景情况:
- 慢性心力衰竭 (CHF) 在患有多种并发病的老年患者中很常见.
- 在CHF患者中,药物药理动力学 (PK) 可以显著改变.
- 了解这些PK变化对于安全有效的药物治疗至关重要.
研究的目的:
- 系统地审查CHF患者的药理动力学研究.
- 为了将药物物理化学性质 (PCP) 与PK参数变化相关联.
- 为调整CHF药物剂量提供指导.
主要方法:
- 来自多个数据库 (例如PubMed,CNKI) 的CHF患者的PK研究的系统综述.
- 包括106篇符合特定标准的文章 (PK数据,人口统计,CHF诊断).
- 对PK数据,PCP和偏差风险评估 (ROBINS-I) 的描述性和相关性分析.
主要成果:
- 在血蛋白结合 (PPB),药物脂性和分布量之间发现的相关性.
- 药物PCP,半衰期和清除是相关的,特别是对于高度与蛋白质结合的药物.
- 慢性肺炎的低albuminemia可能会增加脂性药物分布,并延长半衰期,减少清除.
结论:
- 药物的物理化学特性显著影响慢性心力衰竭中的药理学参数.
- 改变的PK,包括分布量,半衰期和清除的变化,需要谨慎的药物管理.
- 这些发现支持根据个人药物特性和CHF患者的病情量身定制药物治疗方案.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
233
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
233
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
195
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
195
01:30Heart Failure V: Medical Management
215
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
215
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
228
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
228
01:22Heart Failure Drugs: Diuretics
796
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
796